fig3
Figure 3. Immunoregulatory effects of pEVs and purified pEVs on RAW cells. (A) Fold changes in pro-inflammatory marker expression in RAW cells pre-stimulated with E. coli LPS (1 µg/mL) for 2 h, washed three times with PBS, and subsequently stimulated with 100 ng/mL LPS, either alone or in combination with pEVs or purified pEVs (1 × 109 particles/mL) for 24 h; (B) Concentrations of TNF-α and IL-1β in the culture medium of LPS-stimulated RAW cells. Data are expressed as the mean ± SD of three independent experiments, each using paired pEV and purified pEV preparations from a different plasma donor (n = 3). Statistical significance is indicated as *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. IL-1β: Interleukin-1β; Il6: interleukin-6; Ccr7: C-C Motif Chemokine Receptor 7; Cd86: Cluster of differentiation 86; LPS: lipopolysaccharide; Nos2: nitric oxide synthase 2; Osm: Oncostatin M; pEVs: plasma-derived extracellular vesicles; PBS: phosphate-buffered saline; RAW: RAW264.7 macrophages; SD: standard deviation; TNF-α: tumour necrosis factor-α.





